Timothy Mariano

Dr. Mariano brings a multidimensional background in engineering, psychology and drug development to his role, which is focused on providing medical, clinical and regulatory leadership for our growing pipeline of prescription digital therapeutics. He also advances scientific partnerships and is a core member of the company’s Scientific Advisory Board.

Before joining the company, Dr. Mariano was medical director at Sage Therapeutics, where he led the clinical development, medical monitoring and regulatory strategy for several early and late-stage studies. Before that, Dr. Mariano was an assistant psychiatrist at Brigham and Women’s Hospital and an instructor at Harvard Medical School. He was also a consultant to Ad Scientiam, a developer of digital patient monitoring solutions, and to Janssen Pharmaceuticals for its esketamine program for depression. Before starting his consulting work, Dr. Mariano completed his research-track residency training in psychiatry at Brown University’s Warren Alpert Medical School. A licensed psychiatrist practicing at the Providence VA Medical Center in Rhode Island, Dr. Mariano also maintains a research affiliation at the Center for Neurorestoration and Neurotechnology (CfNN), and an academic position as Adjunct Assistant Professor of Biology and Human Behavior at Brown University. He is a prolific researcher with dozens of articles published in peer-reviewed publications, and his scholarly interests have focused on noninvasive brain stimulation for neuropsychiatric disorders and, more recently, novel teletherapy approaches. Dr. Mariano holds a Bachelor of Science degree in biomedical engineering from Harvard College; completed his medical training and a PhD in biomedical engineering at Case Western Reserve University; and holds a Master of Science degree in experimental psychology from the University of Oxford.